Takara Bio Inc.
4974.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -¥5,401 | -¥1,510 | ¥2,420 | -¥1,891 |
| Dep. & Amort. | ¥1,336 | ¥1,360 | ¥1,104 | ¥1,345 |
| Deferred Tax | ¥0 | ¥0 | ¥0 | ¥0 |
| Stock-Based Comp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Change in WC | ¥340 | ¥2,500 | -¥3,487 | -¥2,760 |
| Other Non-Cash | ¥4,857 | -¥438 | ¥924 | ¥2,090 |
| Operating Cash Flow | ¥1,132 | ¥1,912 | ¥961 | -¥1,216 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -¥11,779 | -¥377 | -¥266 | -¥8,488 |
| Net Acquisitions | ¥108 | -¥6,494 | -¥545 | ¥0 |
| Inv. Purchases | -¥528 | -¥977 | -¥42 | -¥420 |
| Inv. Sales/Matur. | ¥859 | ¥948 | ¥25 | -¥375 |
| Other Inv. Act. | -¥1 | ¥20 | -¥406 | ¥1 |
| Investing Cash Flow | -¥11,341 | -¥6,880 | -¥1,234 | -¥9,282 |
| Financing Activities | – | – | – | – |
| Debt Repay. | ¥9,951 | -¥50 | ¥0 | ¥0 |
| Stock Issued | ¥0 | ¥0 | ¥0 | ¥0 |
| Stock Repurch. | ¥0 | ¥0 | ¥0 | ¥0 |
| Dividends Paid | -¥68 | -¥1,980 | -¥1 | -¥1 |
| Other Fin. Act. | -¥121 | ¥0 | -¥48 | -¥55 |
| Financing Cash Flow | ¥9,762 | -¥2,030 | -¥49 | -¥56 |
| Forex Effect | -¥2,565 | ¥1,968 | -¥1,347 | ¥1,035 |
| Net Chg. in Cash | -¥3,012 | -¥5,030 | -¥1,669 | -¥9,519 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | ¥22,006 | ¥27,036 | ¥28,705 | ¥38,224 |
| End Cash | ¥18,994 | ¥22,006 | ¥27,036 | ¥28,705 |
| Free Cash Flow | -¥10,647 | ¥1,535 | ¥695 | -¥9,704 |